Search results :

Anastrozole

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: L02BG03

Side effects

Options: Show MedDRA Preferred Terms,   display all 31 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Digestion impaired 21% - 38.4% x x x x x x x x x x x x x
Hot flush 0.0001% - 40.9% x x x x x x x x x x x x x x x x x x x x
Vasodilation 20.7% - 25.3% x x x x x x x x x x x x x
Mood alteration NOS 0.2% - 19.4% x x x x x x x x x x x x x
Fatigue 0.3% - 19% x x x x x x x x x x x x x x
Asthenia 0.3% - 19% x x x x x x x x x x x x x x x x x x x x
Stiffness 0.0001% - 35.9% x x x x
Arthritis 14% - 16.6% x x x x x x x x x x x x x x x x x
Pain 10.7% - 17.2% x x x x x x x x x x x x x x x
Arthralgia 0.0001% - 35.9% x x x x x x x x x x x x x x x x x x x x
Nausea 0.7% - 20.7% x x x x x x x x x x x x x x x x x x x x
Back pain 7.51% - 13.3% x x x x x x x x x x x x x x x
Oedema 7% - 14% x x x x x x x x x x x x x
Bone pain 5.98% - 12% x x x x x x x x x x x x x x x x x
Oedema peripheral 5% - 11.1% x x x x x x x x x x x x x x x
Accidental injury 9.79% - 10.1% x x x x x x x x x x x x x
Lymphoedema 9% - 11% x x x x x x x x x x x x x x x
Pharyngitis 5.93% - 14.3% x x x x x x x x x x x x x x x
Cough 8-11% x
Headache 7.83% - 18% x x x x x x x x x x x x x x x x x x x x
Cough increased 7% - 10.9% x x x x x x x x x x x x x x
Dyspnoea 7.57% - 21% x x x x x x x x x x x x x x x
Infection 8.92% - 9.22% x x x x x x x x x x x x x
Urinary tract infection 7.89% - 10.1% x x x x x x x x x x x x x
Constipation 6.87% - 12.9% x x x x x x x x x x x x x x
Abdominal pain 5.69% - 8.92% x x x x x x x x x x x x x x
Rash postmarketing, 5.73% - 12.5% x x x x x x x x x x x x x x x x x x x x
Vomiting 0.7% - 12.8% x x x x x x x x x x x x x x x x x x x x
Insomnia 5.93% - 9.99% x x x x x x x x x x x x x x x
Osteoporosis 7% - 10.5% x x x x x x x x x x x x x x x
Hypertension 4.94% - 13% x x x x x x x x x x x x x x x
Anorexia 4% - 9% x x x x x x x x x x x x x x x x x x x
Chest pain 4.85% - 7.32% x x x x x x x x x x x x x x
Diarrhoea 2.77% - 8.57% x x x x x x x x x x x x x x x x x x x
Hypercholesterolaemia 3.49% - 8.99% x x x x x x x x x x x x x x x x x x
Breast tenderness 7% x
Influenza-like symptoms 7% x
Breast pain 5.46% - 8.12% x x x x x x x x x x x x x
Cataract specified 5.89% - 6.88% x x x x x x x x x x x x x
Influenza 5.66% - 6.92% x x x x x x x x x x x x x
Dyspepsia 5.46% - 6.66% x x x x x x x x x x x x x
Vulvovaginitis 4.85% - 6.27% x x x x x x x x x x x x x x
Arthropathy 5.04% - 6.69% x x x x x x x x x x x x x x x
Gastrointestinal disorder 5.11% - 6.79% x x x x x x x x x x x x x
Dizziness 4.31% - 7.63% x x x x x x x x x x x x x x
Cataract 0.2% - 7.08% x x x x x x x x x x x x x x
Anxiety 5% - 6.31% x x x x x x x x x x x x x x
Depression 1.98% - 13.4% x x x x x x x x x x x x x
Sinusitis 5.14% - 5.95% x x x x x x x x x x x x x
Bronchitis 4.95% - 5.4% x x x x x x x x x x x x x
Myalgia postmarketing, 5.17% - 5-36% x x x x x x x x x x x x x x x x
Paraesthesia 3.56% - 6.95% x x x x x x x x x x x x x x
Pelvic pain 4.55% - 7% x x x x x x x x x x x x x x
Dry mouth 4% - 6% x x x x x x x x x x x x x x
Neoplasm 4.65% - 5.24% x x x x x x x x x x x x x
Breast neoplasm 4.49% - 5.3% x x x x x x x x x x x x x
Cyst 4.46% - 5.24% x x x x x x x x x x x x x
Sweating 1% - 6.32% x x x x x x x x x x x x x x
Vaginal inflammation 4.04% - 5.11% x x x x x x x x x x x x x
Leukorrhea 1.78% - 9.24% x x x x x x x x x x x x
Anaemia 3.65% - 5.14% x x x x x x x x x x x x x
Weight increased 1.53% - 13% x x x x x x x x x x x x x x
Thromboembolism 1.63% - 6.46% x x x x x x x x x x x x x x
Vaginal discharge 0.0001% - 13.2% x x x x x x x x x x x x x x
Cardiovascular disorder 0.2% - 4.43% x x x x x x x x x x x x x x
Hypertonia 3% - 5.09% x x x x x x x x x x x x x x
Tumour flare 2.96% - 3.52% x x x x x x x x x x x x x x
Vaginal haemorrhage 0.0001% - 10.4% x x x x x x x x x x x x x x x x x x x
Fracture 0.0001% - 11% x x x x x x x x x x x x x x x x x x
Angina pectoris 1.81% - 2.43% x x x x x x x x x x x x x x x x x
Lethargy 1.19% - 2.94% x x x x x x x x x x x x x
Thromboembolic event 0.0003% - 4.88% x x x x x x x x x x x x x
Myocardial infarction 1.29% - 1.36% x x x x x x x x x x x x x
Vaginal dryness 0.587% - 3% x x x x x x x x x x x x x x x x x x x
Hip fracture 0.84% - 0.906% x x x x x x x x x x x x x
Coronary artery disease 0.841% - 0.873% x
Myocardial ischaemia 0.517% - 0.776% x
Endometrial cancer 0.02% - 0.549% x x x x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x x x x x x
Angioedema postmarketing x x x x x x x x x x x x
Erythema multiforme postmarketing x x x x x x x x x x x x
Hepatitis postmarketing x x x x x x x x x x x x x x x x x x
Hypercalcaemia postmarketing x x x x
Hypersensitivity postmarketing x x x x x x x x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x x x x
Urticaria postmarketing x x x x x x x x x x x x x x x x x x
Trigger finger postmarketing x x x x x x x x x x x x x x x x x
Alopecia x x x x x x x x x x x x x x x x x x x
Blister x x x x x x x x x x x x x
Neoplasm malignant x x x x x x x
Carpal tunnel syndrome x x x x x x x x x x x x x x x x x x
Cerebral infarction x
Neck pain x x x x x x x x x x x x x
Confusional state x x x x x x x x x x x x x
Dysphagia x x x x x x x x x x x x x
Dysgeusia x
Body temperature increased x x x x x x x x x x x x x
Haemorrhage x x x x x x x
Hepatitis toxic x
Inflammation x x x x x x x x x x x x x
Jaundice x x x x x x x x x x x x x
Leukopenia x x x x x x x x x x x x x
Menopause x
Musculoskeletal disorder x
Nervousness x x x x x x x x x x x x x
Pruritus x x x x x x x x x x x x x
Pulmonary embolism x
Henoch-Schonlein purpura x x
Rhinitis x x x x x x x x x x x x x
Cerebrovascular accident x x
Swelling x x x x x x x x x x x x x
Thrombophlebitis x x x x x x x x x x x x x
Thrombosis x
Ulcer x x x x x x x x x x x x x
Erythema x x x x
Weight decreased x x x x x x x x x x x x x
Gamma-glutamyltransferase increased x x x x x x x x x x x x x
Phosphatase alkaline increased x x x x x x x x x x x x x
Aspartate aminotransferase increased x x x x x x x x x x x x x
Alanine aminotransferase increased x x x x x x x x x x x x x
Lipid metabolism disorder x
Joint stiffness x x
Malaise x x x x x x x x x x x x x
Increased appetite 0% - 5.14% x x x x x x x x x x x x x
Hepatotoxicity x
Cutaneous vasculitis x x
Hepatobiliary disease x x x x
Hepatitis acute x
Anaphylactoid reaction x x x
Neuropathy x
Osteoporotic fracture
Hepatic pain x x x x x x x x x x x x x
Low density lipoprotein increased x x x x x x x x x x x x x
Cholesterol serum elevated x x x x x x x x x x x x x
Emotional distress x
Sweating increased
Oestrogenic effect x
Raised liver function tests x
Cerebral ischaemia x
High cholesterol x x x x x x x x x x x x x
Retinal vein thrombosis x
Ageusia x
Somnolence x x x x x x x x x x x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Anastrozole / ANASTROZOLE TABLETS

Side effects:24
Source:medicines.org.au

ANASTROZOLE

Side effects:28
Source:FDA Structured Product Label

Anastrozole / ARIMIDEX

Side effects:36
Source:medicines.org.au

Anastrozole / ARIANNA

Side effects:37
Source:medicines.org.au

Anastrozole

Side effects:50
Source:BC Cancer

ANASTROZOLE / ARIMIDEX TAB 1MG

Side effects:108
Source:Health Canada

Anastrozole

Side effects:108
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:108
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:108
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:108
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:108
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:109
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:109
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:109
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:109
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:110
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:110
Source:FDA Structured Product Label

ANASTROZOLE

Side effects:114
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label